JNBA Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

JNBA Financial Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.97K	Hold	8	–	–	﹤0.01%	651
2026 Q1	$3.57K	Buy	+8	New	+$3.73K	﹤0.01%	656
2025 Q1	–	Sell	-3	Closed	-$1.21K	–	686
2024 Q4	$1.21K	Hold	3	–	–	﹤0.01%	612
2024 Q3	$1.4K	Hold	3	–	–	﹤0.01%	614
2024 Q2	$1.41K	Hold	3	–	–	﹤0.01%	592
2024 Q1	$1.25K	Hold	3	–	–	﹤0.01%	622
2023 Q4	$1.22K	Hold	3	–	–	﹤0.01%	636
2023 Q3	$1.04K	Buy	+3	New	+$1.05K	﹤0.01%	667
2019 Q3	–	Sell	-13	Closed	-$2K	–	704
2019 Q2	$2K	Hold	13	–	–	﹤0.01%	617
2019 Q1	$2K	Hold	13	–	–	﹤0.01%	516
2018 Q4	$2K	Buy	+13	New	+$2.25K	﹤0.01%	490
2018 Q3	–	Sell	-13	Closed	-$2K	–	716
2018 Q2	$2K	Hold	13	–	–	﹤0.01%	496
2018 Q1	$2K	Hold	13	–	–	﹤0.01%	467
2017 Q4	$2K	Hold	13	–	–	﹤0.01%	455
2017 Q3	$2K	Hold	13	–	–	﹤0.01%	445
2017 Q2	$2K	Hold	13	–	–	﹤0.01%	429
2017 Q1	$1K	Buy	+13	New	+$1.15K	﹤0.01%	455
2016 Q4	–	Sell	-453	Closed	-$40K	–	1330
2016 Q3	$40K	Buy	+453	New	+$42.8K	0.01%	593
2015 Q4	–	Sell	-45	Closed	-$5K	–	543
2015 Q3	$5K	Hold	45	–	–	﹤0.01%	415
2015 Q2	$6K	Hold	45	–	–	﹤0.01%	398
2015 Q1	$5K	Hold	45	–	–	﹤0.01%	428
2014 Q4	$5K	Hold	45	–	–	﹤0.01%	426
2014 Q3	$5K	Buy	+45	New	+$4.28K	﹤0.01%	444

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JNBA Financial Advisors's VRTX Position: Q2 2026 in Review

JNBA Financial Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 8 shares worth $3.97K. The position accounts for ﹤0.01% of the portfolio, ranked #651.

JNBA Financial Advisors first reported a position in VRTX in Q3 2014 and has held it in 23 quarters since. The position peaked at $40K in Q3 2016. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

JNBA Financial Advisors held 8 shares of Vertex Pharmaceuticals worth $3.97K as of Q2 2026.
JNBA Financial Advisors left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #651 holding.
JNBA Financial Advisors first reported a position in Vertex Pharmaceuticals in Q3 2014 and has held it in 23 quarters since.
JNBA Financial Advisors's Vertex Pharmaceuticals position peaked at $40K in Q3 2016.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.